What is the success rate of traditional Chinese medicine in treating mycoplasma?

Mycoplasma is a virus that can infect people. If a person has poor immunity, he or she can easily be infected and develop the disease. Some people think that after being infected with this virus, Western medicine will not be effective, so they want to try traditional Chinese medicine. So, how effective is traditional Chinese medicine in treating mycoplasma infection? What are the specific treatment methods? Let's take a look.

After several years of development and scientific research, the traditional Chinese medicine Mycoplasma No. 1 for treating Mycoplasma and Chlamydia has been upgraded again according to the different symptoms of each patient. Different formulations of drugs for treating mycoplasma and chlamydia are formulated. The treatment rate is over 98%. It has a significant effect on the treatment of severe recurrent drug-resistant mycoplasma infections. From 2001 to today, the treatment rate has increased from more than 60% to more than 98%.

According to relevant statistical data, a sample survey from August 2008 to February 2009 was conducted on 800 women aged 22 to 50 who used the traditional Chinese medicine Zhiyuan No. 1 to treat ureaplasma urealyticum. All of them had a history of sexual life and had varying degrees of increased leucorrhea accompanied by subjective symptoms and positive ureaplasma urealyticum tests, as well as 400 women with recurrent Mycoplasma hominis infection after multiple treatments. 320 cases of recurrent ureaplasma urealyticum and mycoplasma hominis co-infection were analyzed after treatment with Mycoplasma No. 1. Among the 800 cases of vaginal ureaplasma urealyticum infection, 2 women showed positive results during treatment, and the other 798 women all turned negative after treatment. The effective cure rate was over 99.75%. Among them, 540 cases received 2 courses of treatment and 260 cases received 1 course of treatment. 400 cases of Mycoplasma hominis were treated, of which 290 women received 2 courses of treatment and 106 women received 1 course of treatment. Two women showed weak positive results after taking the medicine, and two women tested positive after taking the medicine. The effective cure rate was over 99%.

320 women with a history of sexual life who were recurrently infected with Ureaplasma urealyticum and Mycoplasma hominis were all given two courses of medication and subjected to microbiological culture tests, and all turned negative. However, most of these patients are accompanied by inflammatory complications, which should be treated separately.

It is reported that, under normal circumstances, doctors in domestic hospitals use Western antibiotics to treat mycoplasma and chlamydia diseases, which have serious side effects, high drug resistance, and high recurrence rates;

However, the use of traditional Chinese medicine has fewer side effects, no possibility of recurrence, and no drug resistance. The use of traditional Chinese medicine to treat mycoplasma diseases is still rare in China. Currently, the "Zhiyuan No. 1" developed by Jiao's Traditional Chinese Medicine has obtained the national patent certificate and is expected to pass the national medicine approval review within three years. Chinese medicine has a long history and has a glorious history of thousands of years. I hope that in the hands of our generation of Chinese people, it can be carried forward and more people can benefit from it.

Ureaplasma urealyticum, Mycoplasma hominis, and Chlamydia are all common diseases we have. Many people would not expect to get such diseases. When gynecological inflammation cannot be detected again and again, Dr. Jiao recommends that you should pay attention to checking for mycoplasma or chlamydia. When there are repeated unexplained miscarriages, you should also pay attention to checking for mycoplasma and chlamydia. If pelvic inflammatory disease and adnexitis cannot be improved after long-term treatment, relevant examinations should also be carried out. In order to achieve the purpose of early detection and early treatment.